Cai W, Nguyen MQ, Wilski NA, Purwin TJ, et al. A Genome-wide screen identifies PDPK1 as a target to enhance the efficacy of MEK1/2 inhibitors in NRAS mutant melanoma. Cancer Res 2022 Jun 3. pii: 699338. doi: 10.1158/0008-5472.CAN-21-3217.
PMID: 35657206